You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 248 No. 17, November 5, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (52)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Diflunisal

A New Oral Analgesic With an Unusually Long Duration of Action

James A. Forbes, MS; William T. Beaver, MD; E. Hartley White, DDS; R. Wendell White, DDS; Gloria B. Neilson, RN; Robert W. Shackleford, MD

JAMA. 1982;248(17):2139-2142.


Abstract

The analgesic efficacy of single 500- and 1,000-mg doses of diflunisal (Dolobid), a new nonsteroidal anti-inflammatory analgesic, was compared in a double-blind study with that of acetaminophen, 600 mg, the combination of acetaminophen, 600 mg, with codeine phosphate, 60 mg, and placebo in 159 oral surgery outpatients. Using a self-rating record, patients rated their pain and its relief hourly for 12 hours after medication. Both doses of diflunisal were significantly more effective than acetaminophen alone and produced peak analgesia comparable to that of the acetaminophen-codeine combination. Diflunisal proved to have an unusually long duration of analgesic action. Acetaminophen and the combination were significantly superior to placebo through hours 2 and 5, respectively; both doses of diflunisal were significantly superior through the end of the 12-hour observation period. None of the active treatments produced more side effects than the placebo.

(JAMA 1982;248:2139-2142)



Author Affiliations

From the Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore (Mr Forbes); the Departments of Pharmacology and Anesthesia, Georgetown University Schools of Medicine and Dentistry, Washington, DC (Dr Beaver); the White Oral Surgery Clinic, Salt Lake City (Drs E. H. and R. W. White and Ms Neilson); and Merck Sharp & Dohme Research Laboratories, West Point, Pa (Dr Shackleford).


Footnotes

Read in part before the 81st annual meeting of the American Society for Clinicial Pharmacology and Therapeutics, San Francisco, March 19, 1980.

Reprint requests to 5 S Main St, Shrewsbury, PA 17361 (Mr Forbes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Codeine phosphate in paediatric medicine
Williams et al.
Br J Anaesth 2001;86:413-421.
ABSTRACT | FULL TEXT  

Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review
de Craen et al.
BMJ 1996;313:321-325.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.